Home Cart 0 Sign in  
X

[ CAS No. 1603-40-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1603-40-3
Chemical Structure| 1603-40-3
Chemical Structure| 1603-40-3
Structure of 1603-40-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1603-40-3 ]

Related Doc. of [ 1603-40-3 ]

Alternatived Products of [ 1603-40-3 ]

Product Details of [ 1603-40-3 ]

CAS No. :1603-40-3 MDL No. :MFCD00006320
Formula : C6H8N2 Boiling Point : -
Linear Structure Formula :- InChI Key :RGDQRXPEZUNWHX-UHFFFAOYSA-N
M.W : 108.14 Pubchem ID :15347
Synonyms :

Calculated chemistry of [ 1603-40-3 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.61
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.24
Log Po/w (XLOGP3) : 0.87
Log Po/w (WLOGP) : 0.98
Log Po/w (MLOGP) : 0.54
Log Po/w (SILICOS-IT) : 1.14
Consensus Log Po/w : 0.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.61
Solubility : 2.63 mg/ml ; 0.0243 mol/l
Class : Very soluble
Log S (Ali) : -1.27
Solubility : 5.79 mg/ml ; 0.0536 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.99
Solubility : 1.11 mg/ml ; 0.0103 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.13

Safety of [ 1603-40-3 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P280-P301+P310 UN#:2810
Hazard Statements:H301+H311+H331-H373 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1603-40-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1603-40-3 ]
  • Downstream synthetic route of [ 1603-40-3 ]

[ 1603-40-3 ] Synthesis Path-Upstream   1~57

  • 1
  • [ 1603-40-3 ]
  • [ 2369-18-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
[2] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[3] Journal of the American Chemical Society, 1949, vol. 71, p. 1125
[4] Journal of Organic Chemistry, 1949, vol. 14, p. 509,513
  • 2
  • [ 1603-40-3 ]
  • [ 393-55-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Journal of the American Chemical Society, 1949, vol. 71, p. 1125
[3] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 3
  • [ 1603-40-3 ]
  • [ 101860-97-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 247 - 255
  • 4
  • [ 108-99-6 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
YieldReaction ConditionsOperation in experiment
1928 g With ammonia; sodium; ethanolamine In toluene at 60 - 170℃; Autoclave; Inert atmosphere; Large scale 1) Add 9021g of toluene, 538g of sodium metal, 70g of ethanolamine and 1900g of 3-picoline to the autoclave. After tightening the autoclave, open the autoclave inlet and the addition port of the dropping tank, and open the dropping tank And the kettle body valve, the hose through the feeding port into the bottom of the tank, with nitrogen replacement air for 1min, closed the lid of the feeding port, warmed to 60 , dropping liquid ammonia, control the pressure in the autoclave 3MPa, the final Liquid ammonia added amount of 600g. Fully respond.2) The temperature was raised to 170 ° C, nitrogen was filled to a pressure of 5 MPa, and the reaction was sufficiently completed. When the pressure in the autoclave increased to 5.5 MPa,Pressure relief to 5MPa, repeat this operation until the pressure inside the reactor does not rise as the end of the reaction, down to room temperature.3) The ammoniated liquid was taken out and slowly added dropwise to water (9 kg). The mixture was stirred and hydrolyzed and extracted, and the mixture was allowed to stand still. After the aqueous phase was extracted again with 3 L of toluene, the oil phases were combined and the oil phase was quantified by gas chromatography.Among them, 1928g of 2-amino-5-methylpyridine and 144g of 2-amino-3-methylpyridine.
Reference: [1] Patent: US2456379, 1946, ,
[2] Patent: CN106496105, 2017, A, . Location in patent: Paragraph 0024; 0025; 0026; 0027; 0028; 0029; 0030-0035
  • 5
  • [ 1003-73-2 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 12, p. 4554 - 4557
  • 6
  • [ 1603-40-3 ]
  • [ 407-21-6 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
  • 7
  • [ 1603-40-3 ]
  • [ 3430-19-1 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
  • 8
  • [ 108-99-6 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
YieldReaction ConditionsOperation in experiment
1928 g With ammonia; sodium; ethanolamine In toluene at 60 - 170℃; Autoclave; Inert atmosphere; Large scale 1) Add 9021g of toluene, 538g of sodium metal, 70g of ethanolamine and 1900g of 3-picoline to the autoclave. After tightening the autoclave, open the autoclave inlet and the addition port of the dropping tank, and open the dropping tank And the kettle body valve, the hose through the feeding port into the bottom of the tank, with nitrogen replacement air for 1min, closed the lid of the feeding port, warmed to 60 , dropping liquid ammonia, control the pressure in the autoclave 3MPa, the final Liquid ammonia added amount of 600g. Fully respond.2) The temperature was raised to 170 ° C, nitrogen was filled to a pressure of 5 MPa, and the reaction was sufficiently completed. When the pressure in the autoclave increased to 5.5 MPa,Pressure relief to 5MPa, repeat this operation until the pressure inside the reactor does not rise as the end of the reaction, down to room temperature.3) The ammoniated liquid was taken out and slowly added dropwise to water (9 kg). The mixture was stirred and hydrolyzed and extracted, and the mixture was allowed to stand still. After the aqueous phase was extracted again with 3 L of toluene, the oil phases were combined and the oil phase was quantified by gas chromatography.Among them, 1928g of 2-amino-5-methylpyridine and 144g of 2-amino-3-methylpyridine.
Reference: [1] Patent: US2456379, 1946, ,
[2] Patent: CN106496105, 2017, A, . Location in patent: Paragraph 0024; 0025; 0026; 0027; 0028; 0029; 0030-0035
  • 9
  • [ 3430-17-9 ]
  • [ 1603-40-3 ]
Reference: [1] Chemical Communications, 2010, vol. 46, # 6, p. 925 - 927
  • 10
  • [ 2369-18-8 ]
  • [ 1603-40-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 41, p. 7564 - 7567
  • 11
  • [ 18368-76-8 ]
  • [ 1603-40-3 ]
  • [ 6654-69-9 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
  • 12
  • [ 1003-73-2 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 12, p. 4554 - 4557
  • 13
  • [ 18368-76-8 ]
  • [ 1603-40-3 ]
Reference: [1] Chemistry - A European Journal, 2010, vol. 16, # 6, p. 1983 - 1991
  • 14
  • [ 108-99-6 ]
  • [ 1603-40-3 ]
Reference: [1] Chemische Berichte, 1924, vol. 57, p. 1804[2] Chemische Berichte, 1925, vol. 58, p. 1733
[3] Journal of Chemical and Engineering Data, 2007, vol. 52, # 6, p. 2431 - 2435
  • 15
  • [ 1003-73-2 ]
  • [ 1603-40-3 ]
Reference: [1] Bioorganic and medicinal chemistry letters, 2000, vol. 10, # 17, p. 1975 - 1978
  • 16
  • [ 56-23-5 ]
  • [ 108-99-6 ]
  • [ 1603-40-3 ]
Reference: [1] Chemische Berichte, 1924, vol. 57, p. 1804[2] Chemische Berichte, 1925, vol. 58, p. 1733
  • 17
  • [ 1603-40-3 ]
  • [ 3430-17-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Tetrahedron, 2015, vol. 71, # 2, p. 252 - 258
[3] Phosphorus, Sulfur and Silicon and the Related Elements, 2002, vol. 177, # 11, p. 2579 - 2587
[4] Journal of the American Chemical Society, 1946, vol. 68, p. 2574,2576
[5] Journal of the American Chemical Society, 1948, vol. 70, p. 3126
[6] Journal of the Chemical Society, 1949, p. 2094
[7] Organic Magnetic Resonance, 1982, vol. 20, # 4, p. 242 - 248
[8] Gazzetta Chimica Italiana, 1983, vol. 113, # 3/4, p. 227 - 228
[9] Journal of Organic Chemistry, 1998, vol. 63, # 20, p. 6886 - 6890
[10] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
  • 18
  • [ 1603-40-3 ]
  • [ 7521-41-7 ]
Reference: [1] Synthetic Communications, 1987, vol. 17, # 14, p. 1695 - 1700
  • 19
  • [ 1603-40-3 ]
  • [ 20970-75-6 ]
Reference: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 231
[2] Journal of the American Chemical Society, 1952, vol. 74, p. 5967,5969
[3] Journal of Organometallic Chemistry, 1997, vol. 529, # 1-2, p. 135 - 142
[4] Organic Magnetic Resonance, 1982, vol. 20, # 4, p. 242 - 248
  • 20
  • [ 1603-40-3 ]
  • [ 23612-48-8 ]
Reference: [1] Synthesis, 1996, # 7, p. 877 - 882
  • 21
  • [ 1603-40-3 ]
  • [ 4021-07-2 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 5967,5969
  • 22
  • [ 1603-40-3 ]
  • [ 5654-93-3 ]
Reference: [1] Synthesis, 1996, # 7, p. 877 - 882
  • 23
  • [ 1603-40-3 ]
  • [ 402-66-4 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
  • 24
  • [ 1603-40-3 ]
  • [ 10592-27-5 ]
Reference: [1] Patent: CN106279156, 2017, A,
  • 25
  • [ 1603-40-3 ]
  • [ 35905-85-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Tetrahedron, 2015, vol. 71, # 2, p. 252 - 258
  • 26
  • [ 1603-40-3 ]
  • [ 364-22-7 ]
Reference: [1] Journal of the American Chemical Society, 1949, vol. 71, p. 1125
  • 27
  • [ 1603-40-3 ]
  • [ 5654-95-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 247 - 255
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 247 - 255
  • 28
  • [ 1603-40-3 ]
  • [ 18344-51-9 ]
YieldReaction ConditionsOperation in experiment
35%
Stage #1: at 0 - 50℃;
Stage #2: With ammonia In water at 20℃;
3-Methyl-pyridin-2-ylamine (5.0 g, 46.2 mmol) was dissolved in concentrated sulfuric acid (24ml), the mixture was chilled to 0°C and a mixture of fuming nitric acid (d=1.5, 3.5ml) and concentrated sulfuric acid (3.5ml) was added dropwise to the reaction mixture while temperature was kept below 20°C.
The stirred mixture was allowed to warm to 20°C and transferred in portions of 3-5ml into a second flask which was heated to 35-40°C (the temperature was not allowed to rise over 40°C - monitoring carefully the temperature after every addition of a new portion).
The resulting reaction mixture was subsequently stirred for additional 30min at 50°C, cooled to ambient temperature and neutralized with concentrated aqueous ammonia.
This led to the formation of a precipitated which was filtered, washed with water and aqueous DMFA (50percent, 6ml), and recrystallized from DMFA yielding 3-methyl-5-nitro-pyridin-2-ylamine (2.52g, 35percent).
Reference: [1] Patent: EP1894924, 2008, A1, . Location in patent: Page/Page column 36
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[3] Journal of the American Chemical Society, 1955, vol. 77, p. 3154
  • 29
  • [ 1603-40-3 ]
  • [ 21901-34-8 ]
YieldReaction ConditionsOperation in experiment
75% With sulfuric acid; nitric acid In water at 10 - 35℃; A 3-necked, 2-L, round-bottomed flask equipped with a mechanical stirrer, an addition funnel and a thermometer was placed in an ice-water bath. Conc. H2SO4 (150 mL) was added to the flask. 2-Amino-3-methylpyridine (50.0 g, 0.463 mol, Lancaster, CAS 1603-40-3, mp. 29° C., prewarmed in a warm water bath to melt it) was weighed out in a 125 mL Erlenmeyer flask and was subsequently added in small portions via a prewarmed Pasteur pipet with the narrow tip broken off. The Erlenmeyer flask was kept in a warm water bath during the addition to prevent the starting material from solidifying. The temperature rose to ca. 45° C. during the addition and white smoke/fog formed within the flask. Conc. H2SO4 (100 mL) was added to the residual starting material and the mixture was added to the reaction flask. The resulting mixture was a milky-white suspension. A solution of conc. H2SO4 (35 mL) and 70percent nitric acid (35 mL) was premixed with ice-water bath cooling and transferred into the addition funnel. After the internal temperature of the reaction mixture had cooled to 10-15° C. (but not below 10° C.), the premixed H2SO4/HNO3 acid mixture was added dropwise at a rate such that the internal reaction temperature rose to 20-25° C. (5-10 min addition time). After the addition was complete, the ice-water bath was replaced with a tap-water bath. The reaction temperature slowly increased to ca. 30° C. range and then cooled down to room temperature. The reaction should be monitored during this time to ensure that the temperature does not rise too high. The reaction mixture was then stirred overnight and then 70percent nitric acid (35 mL) was added dropwise via the addition funnel to the dark red-brown mixture at a rate of addition such that the temperature did not exceed 35° C. At this time, the reaction flask was sitting in a water bath containing water at room temperature. Water (500 mL) was then added to the reaction flask in portions via addition funnel. The first ca. 150 mL of water was added dropwise while allowing the internal temperature to climb slowly to 50-60° C. The rate of stirring was increased in order to break up any foaming that occurred. Brown gas evolved during the addition of the initial ca. 150 mL of water. The remaining ca. 350 mL of water was added at a faster rate after gas evolution had stopped and a temperature increase was no longer observed. The reaction turned from a dark cloudy brown to a clear orange solution. Some yellow precipitate may form as the reaction cools to below 50° C. The water bath was then removed, and replaced with a heating mantle, and the addition funnel was replaced with a condenser. The reaction mixture (a light orange solution or bright yellow solution) was then heated at 115-118° C. for 1.75-2 h. Additional gas evolution occurred at ca. 115° C. during this time. The reaction mixture was then cooled to room temperature with the aid of an ice-water bath and was then cooled further to 0° C. by adding ice directly into the reaction mixture. The solid that formed was collected on a Buchner funnel and was washed with cold water followed by a minimal amount of cold ethanol followed by a minimal amount of cold ether. The solid was then dried under vacuum to afford 3-methyl-5-nitropyridin-2-ol (53.5 g, 75percent yield) as a pale yellow solid. mp 228-229° C.; 1H NMR (400 MHz, DMSO-d6) δ 12.55 (s, br, 1H), 8.54 (d, J=3.0 Hz, 1H), 8.04 (d, J=2.0 Hz, 1H), 2.04 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 162.2, 135.4, 130.0, 129.5, 128.1, 15.8; LRMS, (ESI) m/e 152.96 [(M-H)-, calcd for C6H5N2O3, 153.03]. Anal. calcd. for C6H6N2O3; C, 46.75, H, 3.92, N, 18.17. Found: C, 46.80, H, 3.79, N, 18.14.
69.2%
Stage #1: at 0 - 30℃; for 18 h;
Stage #2: at 100℃; for 1 h;
Example 5: Synthesis of the 2-(1-ethyleneimine)-3-carbamoyl-5-nitropyridine (compound IV) [Show Image] The reagents used is ( i ) HNO3/H2SO4, followed by H2O; (ii) POCl3; (iii) Na2Cr2O7; (iv) SOCl2, followed by NH4OH; (v) aziridine.Synthesis of the compound 19 A concentrated sulphuric acid (240 mL) was cooled in an ice bath, the starting material compound 18 (50 g, 0.462mol) was slowly added and cooled to 0°C, 35 mL of a mixture in volumetric ratio of 1:1 of a concentrated sulphuric acid (98percent) and a concentrated nitric acid (72percent) was slowly added, the reaction proceeded at 25°C for 15 h, and 35 mL of 72percent HNO3 was added, followed by agitation at 30°C for 3 h. 50 mL of the reaction liquid was taken out and placed into a 1000mL flask. 100 mL of water was added, and the solution so obtained was heated to boiling; then the rest part of the reaction liquid was added in batches to the boiling solution with 50mL per batch. The reaction system so obtained was stirred at 100 °C for additional 1 h. After the reaction was completed, the reaction mixture was poured into 2000 g of ice, and 49.0 g of a yellow precipitate was precipitated. The melting point is 225.9-226.5 °C (water) (M. P. 228.5-229.5°C (water) was reported in the reference)[J.O.C. , 1949, 14, 328-332]. The yield was 69.2percent.
53%
Stage #1: at 20℃; for 15 h; Cooling
Stage #2: at 120℃;
A solution of 2-amino-3-picoline (5 g, 46 mmol) in c-H2SO4 (24 mL) was cooled in an ice bath.
A mixture of c-H2SO4 (3.5 mL) and c-HNO3 (3.5 mL) was added slowly with stirring.
This mixture was then warmed up to rt and stirred for 15 h.
The solution was stirred rapidly while c-HNO3 (3.5 mL) was added.
The mixture was then poured into 60 mL of water and heated to 120 °C until the solvent volume was reduced by half.
The solution was cooled rapidly by placing in an ice bath and by adding ice directly to the solution.
The solid precipitate was filtered, washed with water, and dried to give product 9 as a light brown solid (5.3 g, 75percent).
1H NMR (300 MHz, DMSO-d6) δ: 12.55 (s, 1H), 8.53 (d, J = 3.0 Hz, 1H), 8.04 (d, J = 3.3 Hz, 1H), 2.03 (s, 3H).
Reference: [1] Patent: US2010/29684, 2010, A1, . Location in patent: Page/Page column 5; 13-14
[2] Journal of Medicinal Chemistry, 2009, vol. 52, # 23, p. 7653 - 7668
[3] Patent: EP2366691, 2011, A1, . Location in patent: Page/Page column 9-10
[4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
[5] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[6] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
  • 30
  • [ 1603-40-3 ]
  • [ 22280-56-4 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 328,331
[3] Patent: EP2366691, 2011, A1,
[4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
  • 31
  • [ 1603-40-3 ]
  • [ 3430-21-5 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With bromine In dichloromethane at 0 - 20℃; for 4.66667 h;
Stage #2: With sodium hydroxide In dichloromethane; water
Bromine (15.4 mL, 0.30 mol) was added dropwise to a stirred and cooled (0-2 [°C)] solution of 2-amino-3-picoline (1; 32.44 g, 0.30 mol) in dry [CH2CI2] (1000 mL) over a period of 1 h. The cooling bath was then removed, and the yellowish suspension was stirred at r. t. for 3 h 40 min. The mixture was basified to pH 9 with 2N [NAOH] (145 mL) followed by a mixture of saturated aqueous [NAHC03] (100 mL) -saturated aqueous Na2S203 (10 mL). The organic layer was separated and washed with brine, dried [MGS04] and concentrated to afford 14 (56.83 g, 102percent) as brown solid, which was used in the next step without purification.
68%
Stage #1: Reflux
Stage #2: at 20 - 55℃; for 2.5 h;
Stage #3: With sodium hydroxide In water for 0.5 h;
Example 2
2-amino-3-methylpyridine (10.8g, 0.1mol) and acetic anhydride (12.3g, 0.12mol) was added to a 250ml four-necked flask and was heated to reflux in an oil bath, tracking by thin layer chromatography until the reaction is complete. Afterwards, the reaction was cooled to 20-25°C, the solution was slowly added dropwise bromine (17.6g, 0.11mol) and was reacted at 55°C for 2.5h. Water was added to dissolve all solids. 40mL 40percent sodium hydroxide solution was slowly added dropwise. After the addition, he reaction was continued for 30min. The solution was then filtered, dried, and recrystallized to give 2-amino-3-methyl-5-bromopyridine with a molar yield of 68percent.
65% With N-Bromosuccinimide; ammonium acetate In acetonitrile at 0 - 23℃; for 0.416667 h; 5-Bromo-3-methylpyridin-2-amine (48) [0174] (J. Mol. Catal. A: Chem. 2007, 267, 30-33.) N-Bromosuccinimide (170 g, 0.95 mol) was added to a solution of 47 (99 g, 0.92 mol) and ammonium acetate (7 g, 10 mol percent) in acetonitrile (500 mL). The temperature of the reaction mixture during addition was controlled with an ice bath. After the full amount of NBS was added, the ice bath was removed and the reaction mixture was stirred at room temperature for 25 min, and acetonitrile was removed under reduced pressure. A mixture of ethyl acetate (1 L) and water (1 L) was added to the solid residue. The resulting mixture was stirred and the organic layer was separated. The water layer was extracted with ethyl acetate (3×500 mL). The combined extracts were washed with water (300 mL), saturated sodium bicarbonate solution (500 L), dried with sodium sulfate and evaporated to dryness to give a dark brown solid. The crude product was redissolved in chloroform (300 mL); and the solution was filtered through a thin pad of silica gel, eluting with chloroform. The combined filtrates were evaporated under reduced pressure to yield 48 as a light-brown solid (113 g, 65percent): mp 89-90° C. (lit. (J. Am. Chem. Soc. 1976, 98, 1478-1486) mp 91-93° C.). 1H NMR (300 MHz, CDCl3) 7.97 (d, J=2.3 Hz, 1H), 7.36 (d, J=2.3 Hz, 1H), 4.50 (s, 2H), 2.09 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 156.10, 146.29, 140.03, 118.79, 108.58, 77.72, 77.30, 76.88, 17.27.
56% With dihydrogen peroxide; 1-butylpyridinium bromide; toluene-4-sulfonic acid In 1,2-dimethoxyethane at 80℃; for 24 h; Schlenk technique; Inert atmosphere; Green chemistry General procedure: To a mixture of 2-aminopyridine (0.5 mmol, 1 equiv), p-TSA (0.4 mmol,0.8 equiv), 1-butylpyridinium bromide (1.5 mmol, 3 equiv) in a 50 mL Schlenk tube were added 1,2-dimethoxyethane (2 mL) under air. Then H2O2 (1.2 mmol, 2.4 equiv) was added. The mixture was stirred at 80°C for 24 h. And then the mixture was purified by silica gel column chromatography (petroleum ether/ethyl acetate) to give the products.

Reference: [1] Patent: WO2004/13139, 2004, A2, . Location in patent: Page 25-26
[2] Tetrahedron Letters, 2009, vol. 50, # 9, p. 1007 - 1009
[3] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2001, vol. 40, # 11, p. 1129 - 1131
[4] Patent: CN105348177, 2016, A, . Location in patent: Paragraph 0012; 0016
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 4, p. 1682 - 1697
[6] Patent: US2014/18360, 2014, A1, . Location in patent: Paragraph 0174
[7] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[8] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[9] Journal of Organic Chemistry, 2001, vol. 66, # 4, p. 1310 - 1315
[10] Tetrahedron Letters, 2014, vol. 55, # 36, p. 5058 - 5061
  • 32
  • [ 1603-40-3 ]
  • [ 60524-15-4 ]
Reference: [1] Patent: EP2366691, 2011, A1,
  • 33
  • [ 1603-40-3 ]
  • [ 2032-35-1 ]
  • [ 874-10-2 ]
YieldReaction ConditionsOperation in experiment
98% With hydrogen bromide In ethanol; water at 90℃; for 26 h; 2-amino-3-methylpyridine (10 g, 92.5 mmol) and 2-bromo-1,1-diethoxyethane (36.4 g, 185 mmol) were dissolved in ethanol (100 mL) Then, 48percent aqueous hydrogen bromide solution (9 mL) was slowly added dropwise to the reaction solution. After the reaction system was heated to 90 ° C for 26 hours, LC-MS detection reaction has ended, And then cooled to room temperature. The first reaction in the system of ethanol decompression distillation, The excess hydrobromic acid in the reaction was neutralized with excess saturated sodium bicarbonate water (100 mL) and sodium bicarbonate solids (15 g). The remaining mixture was extracted with ethyl acetate (200 mL x 3) All organic phases were then mixed and washed once with deionized water (100 mL) and saturated brine (100 mL) Dried over anhydrous sodium sulfate, Press the steam to remove the solvent. The remaining mixture was purified by silica gel column chromatography (eluent: dichloromethane / methanol = 0-10percent), To give 8-methyl-imidazo [1,2-a] pyridine (12 g, yield 98percent).
Reference: [1] Patent: CN106279160, 2017, A, . Location in patent: Paragraph 0259; 0263; 0264; 0265
[2] Bulletin of the Chemical Society of Japan, 1999, vol. 72, # 6, p. 1327 - 1334
  • 34
  • [ 107-20-0 ]
  • [ 1603-40-3 ]
  • [ 874-10-2 ]
YieldReaction ConditionsOperation in experiment
62% With sodium chloride; sodium hydrogencarbonate In water EXAMPLE IV
8-METHYLIMIDAZO[1,2-A]PYRIDINE
To a mixture of chloroacetaldehyde [25.4 mL (0.2 mole) of a 50percent aqueous solution]and 18.8 g (0.2 mole) of 2-amino-3-methylpyridine in 150 mL of water was added 16.8 g (0.2 mole) of sodium bicarbonate.
After being stirred at 25° C. for 3 days, the mixture was acidified with concentrated hydrochloric acid and stirred an additional 30 minutes.
After the pH was adjusted to 10 by addition of sodium hydroxide, the mixture was saturated with sodium chloride and extracted with ether.
The ether extracts were dried and concentrated to give 16.3 g (62percent) of a liquid residue, bp 68°-70° C. at 0.1 Torr.
Imidazo[1,2-a]pyridine, bp 61°-66° C. at 0.1 Torr., was prepared in an analogous manner.
Reference: [1] Journal of Medicinal Chemistry, 1992, vol. 35, # 23, p. 4415 - 4424
[2] Patent: US5039691, 1991, A,
[3] Patent: EP1790650, 2007, A1, . Location in patent: Page/Page column 45
  • 35
  • [ 1603-40-3 ]
  • [ 17157-48-1 ]
  • [ 874-10-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 14, p. 2856 - 2859
  • 36
  • [ 1603-40-3 ]
  • [ 70-23-5 ]
  • [ 67625-40-5 ]
Reference: [1] Farmaco, Edizione Scientifica, 1983, vol. 38, # 12, p. 911 - 928
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 11, p. 2790 - 2794
  • 37
  • [ 1603-40-3 ]
  • [ 3430-18-0 ]
Reference: [1] European Journal of Medicinal Chemistry, 1989, vol. 24, # 3, p. 249 - 258
[2] Journal of Medicinal Chemistry, 2012, vol. 55, # 4, p. 1682 - 1697
[3] Patent: US2014/18360, 2014, A1,
  • 38
  • [ 1603-40-3 ]
  • [ 65550-77-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 1989, vol. 24, # 3, p. 249 - 258
  • 39
  • [ 1603-40-3 ]
  • [ 65550-78-9 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 16, p. 5356 - 5359
  • 40
  • [ 1603-40-3 ]
  • [ 36404-90-7 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 41
  • [ 1603-40-3 ]
  • [ 128071-75-0 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
[2] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 42
  • [ 1603-40-3 ]
  • [ 131747-55-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 43
  • [ 1603-40-3 ]
  • [ 116308-35-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 44
  • [ 1603-40-3 ]
  • [ 131747-57-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 45
  • [ 1603-40-3 ]
  • [ 131747-43-8 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 46
  • [ 1603-40-3 ]
  • [ 24424-99-5 ]
  • [ 138343-75-6 ]
YieldReaction ConditionsOperation in experiment
86% at 20 - 58℃; for 4.5 h; A solution of di-tert-butyl dicarbonate (50.0 g) in n-hexane (55 mL) was heated to 58°C and stirred. To this solution, a solution of 2-aminopicoline (15.5 g) in ethyl acetate (20 mL) was added dropwise. After heated at 58°C for three hours, it was cooled to room temperature. After addition of n-hexane (30 mL), it was stirred for 1.5 hours. The deposited precipitate was collected by filtration and dried and 25.8 g (86percent) of the title compound was obtained as a white solid. MS(FAB) m/z:209 (M + H)+.
82% for 2 h; Reflux; Large scale BOC anhydride (3.2 kg, 14.7 mmol) was dissolved in hexane (3.5 L) and heated to reflux. 3-Methyl-pyridin-2-ylamine S5 (995 g, 9.2mmol) in EtOAc (1 L) was added dropwise over 2 hours, then the reaction was cooled to 20°C. Following dilution with hexane (2 L), the mixture was stirred for a further hour and the resultent solid collected by filtration, washing with hexane to affords (3-methyl-pyridin-2-yl)-carbamicacid tert-butyl ester S6 (1.56 kg, 82percent yield) 1H NMR (400 MHz, CDCl3):1.55 (9H, s), 2.32 (3H, s), 6.87 (1H, s(b)), 7.07 (1H, dd), 7.55 (1H, d), 8.29 (1H, d)
71% at 25 - 60℃; for 19 h; Step 1
(3-Methyl-pyridin-2-yl)-carbamic acid tert-butyl ester
3-Methylpyridin-2-amine (20 g, 185 mmol) was dissolved in ethyl acetate (30 mL) and added drop-wise to a solution of di-tert-butyldicarbonate (64.6 g, 296 mmol) in hexanes (72 mL) at 60° C.
After 3 h, the mixture was cooled to 25° C. After 16 h, hexanes (70 mL) were added.
After 2 h, the solid precipitate was filtered, the cake rinsed with hexanes, and then dried to give (3-methyl-pyridin-2-yl)-carbamic acid tert-butyl ester (27.4 g, 71percent) as a white solid. 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 8.24-8.29 (m, 1H) 7.49-7.54 (m, 1H) 7.00-7.07 (m, 1H) 2.30 (s, 3H) 1.52 (s, 9H); LCMS (EI/CI) m/z: 209 [M+H].
68.6% at 20℃; for 4 h; Example 175[0447] (5)-N-(benzo[ ][l,3]dioxol-5-yl)-2-(2-(3-ethyl-2-methyl-lH-pyrrolo[2,3- b]pyridin- 1 -yl)acetamido)-N-methyl-3-phenylpropanamideExample 175 A. Preparation of tert-butyl (3-methylpyridin-2-yl)carbamate[0448] To a solution of 3-methylpyridin-2-amine (15 g, 0.14 mol, 1.0 eq) in EtOAc (30 mL) and petroleum ether (120 mL), was added Boc20 (48.5 g, 0.55 mol, 1.6 eq). The reaction mixture was stirred at room temperature for 4 hours. TLC (petroleum ether/EtOAc 3: 1) showed the reaction was completed. The reaction mixture concentrated in vacuum to give the crude product, which was purified by column chromatography on silica gel to give tert-butyl (3-methylpyridin-2-yl)carbamate (20 g, 0.096 mmol, yield: 68.6percent), LC/MS: m/z M++l = 209.
4.45 g With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 48 h; BOC anhydride (9.6 g, 44 mmol) was added slowly to a solution of 3-methylpyridin-2-amine (4 g, 37 mmol) and cesium carbonate (7.2 g) dry in DMF (20 mL) and the reaction was maintained at rt for 2 d.
The reaction mixture was poured into water (300 mL) with stirring.
The resulting white precipitate was collected by filtration and dried under vacuum to give 4.45 g of tert-butyl 3-methylpyridin-2-ylcarbamate: 1H NMR (300 MHz, CDCl3) δ 8.26 (m, 1H); 7.52 (m, 1H); 7.02 (m, 1H); 6.88 (br s, 1H); 2.29 (s, 3H); 1.52 (s, 9H).

Reference: [1] Organic Process Research and Development, 2010, vol. 14, # 1, p. 168 - 173
[2] Patent: EP1764360, 2007, A1, . Location in patent: Page/Page column 195
[3] Synthesis, 1996, # 7, p. 877 - 882
[4] Tetrahedron, 2008, vol. 64, # 3, p. 500 - 507
[5] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 21, p. 6582 - 6591
[6] Organic Letters, 2009, vol. 11, # 6, p. 1357 - 1360
[7] Journal of Medicinal Chemistry, 2014, vol. 57, # 13, p. 5702 - 5713
[8] Patent: US5681959, 1997, A,
[9] European Journal of Organic Chemistry, 2015, vol. 2015, # 19, p. 4214 - 4223
[10] Patent: US2013/178478, 2013, A1, . Location in patent: Paragraph 0252
[11] Patent: US5681959, 1997, A,
[12] Patent: WO2012/65062, 2012, A1, . Location in patent: Page/Page column 125-126
[13] Patent: WO2006/75638, 2006, A1, . Location in patent: Page/Page column 69-70
[14] Journal of Medicinal Chemistry, 2010, vol. 53, # 3, p. 942 - 950
[15] Synthesis, 1991, # 10, p. 871 - 878
[16] Patent: US5380739, 1995, A,
[17] Patent: US5559081, 1996, A,
[18] Patent: US2008/125459, 2008, A1, . Location in patent: Page/Page column 10
[19] Patent: US2009/298865, 2009, A1, . Location in patent: Page/Page column 6-7
[20] Patent: US2009/318455, 2009, A1, . Location in patent: Page/Page column 68-69; 93
[21] Patent: US2011/112104, 2011, A1, . Location in patent: Page/Page column 5
[22] Patent: US2013/210818, 2013, A1, . Location in patent: Paragraph 0395
[23] Organic Letters, 2013, vol. 15, # 13, p. 3476 - 3479
[24] Chemistry - An Asian Journal, 2013, vol. 8, # 12, p. 2970 - 2973
[25] Patent: CN106279156, 2017, A, . Location in patent: Paragraph 0027; 0035; 0043; 0051; 0059; 0067
[26] Patent: US5212195, 1993, A,
[27] Patent: WO2009/115572, 2009, A2, . Location in patent: Page/Page column 119
  • 47
  • [ 1603-40-3 ]
  • [ 42959-38-6 ]
Reference: [1] Patent: EP2366691, 2011, A1,
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
  • 48
  • [ 1603-40-3 ]
  • [ 145901-11-7 ]
Reference: [1] Patent: US2013/178478, 2013, A1,
  • 49
  • [ 1603-40-3 ]
  • [ 166266-19-9 ]
YieldReaction ConditionsOperation in experiment
6.0 g at 0 - 20℃; for 3 h; Inert atmosphere In a 250-mL round-bottomed flask, a solution of 3-methylpyridin-2-amine (4.57 g, 42.3 mmol) in AcOH (50 mL) was cooled to 0 °C. NIS (9.5 g, 42 mmol, Sigma- Aldrich, India) was added in portions to the above solution at the same temperature under nitrogen atmosphere. The reaction mixture was warmed to room temperature and stirred at room temperature for 3 h. The reaction mixture was diluted with cold water (100 mL), followed by a mixture of 5percent Na2S203 (40 mL) and NaHC03 (100 mL) at room temperature. The solid that formed was filtered, washed thoroughly with water and dried rigorously under reduced pressure at 50 °C to give 5-iodo-3-methyl-2-pyridinamine (6.0 g) as a yellow solid.
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 16, p. 5356 - 5359
[2] Bioorganic Chemistry, 2001, vol. 29, # 4, p. 198 - 210
[3] Journal of the American Chemical Society, 2000, vol. 122, # 27, p. 6512 - 6513
[4] Patent: WO2013/123444, 2013, A1, . Location in patent: Page/Page column 213
  • 50
  • [ 1603-40-3 ]
  • [ 136818-50-3 ]
Reference: [1] Patent: CN107759595, 2018, A,
  • 51
  • [ 1603-40-3 ]
  • [ 100299-08-9 ]
Reference: [1] Heterocycles, 1998, vol. 48, # 4, p. 775 - 778
[2] Heterocycles, 1998, vol. 48, # 4, p. 775 - 778
  • 52
  • [ 1603-40-3 ]
  • [ 156072-86-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 4, p. 1682 - 1697
[2] Patent: US2014/18360, 2014, A1,
  • 53
  • [ 1603-40-3 ]
  • [ 289681-47-6 ]
Reference: [1] Journal of the American Chemical Society, 2000, vol. 122, # 27, p. 6512 - 6513
[2] Bioorganic Chemistry, 2001, vol. 29, # 4, p. 198 - 210
  • 54
  • [ 1603-40-3 ]
  • [ 221675-35-0 ]
Reference: [1] Patent: US2011/112104, 2011, A1,
  • 55
  • [ 1603-40-3 ]
  • [ 866546-07-8 ]
Reference: [1] Patent: CN106279156, 2017, A,
  • 56
  • [ 1603-40-3 ]
  • [ 534-07-6 ]
  • [ 182181-42-6 ]
Reference: [1] Patent: WO2005/68432, 2005, A1, . Location in patent: Page/Page column 201
  • 57
  • [ 1603-40-3 ]
  • [ 1146970-26-4 ]
Reference: [1] Patent: CN106279156, 2017, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1603-40-3 ]

Amines

Chemical Structure| 1603-41-4

[ 1603-41-4 ]

2-Amino-5-methylpyridine

Similarity: 0.84

Chemical Structure| 23612-57-9

[ 23612-57-9 ]

2-Amino-3-hydroxymethylpyridine

Similarity: 0.83

Chemical Structure| 27225-00-9

[ 27225-00-9 ]

2,7-Naphthyridin-1-amine

Similarity: 0.78

Chemical Structure| 71493-76-0

[ 71493-76-0 ]

2-Amino-4-methylnicotinonitrile

Similarity: 0.78

Chemical Structure| 42182-27-4

[ 42182-27-4 ]

2-Amino-4-cyanopyridine

Similarity: 0.77

Related Parent Nucleus of
[ 1603-40-3 ]

Pyridines

Chemical Structure| 1603-41-4

[ 1603-41-4 ]

2-Amino-5-methylpyridine

Similarity: 0.84

Chemical Structure| 23612-57-9

[ 23612-57-9 ]

2-Amino-3-hydroxymethylpyridine

Similarity: 0.83

Chemical Structure| 71493-76-0

[ 71493-76-0 ]

2-Amino-4-methylnicotinonitrile

Similarity: 0.78

Chemical Structure| 42182-27-4

[ 42182-27-4 ]

2-Amino-4-cyanopyridine

Similarity: 0.77

Chemical Structure| 13362-78-2

[ 13362-78-2 ]

(E)-1,2-Di(pyridin-4-yl)ethene

Similarity: 0.76